A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
Will the daily routine of finger pricking to monitor blood sugar levels finally come to…
UK rapid diagnostics company Mologic will convert into a social enterprise after being acquired by…
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…
After decades of neglect from big pharma, radiopharmaceuticals are generating major oncology deals globally. This…
Update (19/05/2020): The gene therapy Zolgensma, developed by the big pharma Novartis and approved in…
Update (02/04/2020): The FDA has concluded an investigation into a data manipulation scandal surrounding the…
Novartis is to acquire The Medicines Company and its late-stage RNA interference drug designed to…
Public and private organizations across Europe will pool their resources in an €80M project to…
The FDA has placed a partial hold on clinical trials testing a new application method…
Development of MorphoSys, Galapagos, and Novartis’ first-in-class antibody drug has been discontinued during a phase…
Many cardiology companies and academics gathered in Paris earlier this week to showcase their latest…